Shareholding disclosure

RENAISSANCE TECHNOLOGIES LLC

Declared position

2.99%

Threshold

Crossed downwards

Timeline

Published

03.08.2017

Transaction

27.07.2017

Voting rights breakdown

Voting rights acquired0%

Voting rights sold2.99%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCH8200022

Beneficial owner

RENAISSANCE TECHNOLOGIES LLC

Declared address

RENAISSANCE TECHNOLOGIES LLC, 10022 New York, NY

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

RENAISSANCE TECHNOLOGIES LLC

Santhera Pharmaceuticals Holding AG03.08.2017TCH8200022

Disclosure summary

RENAISSANCE TECHNOLOGIES LLC disclosed a holding in Santhera Pharmaceuticals Holding AG on the disposal side, published by SIX Exchange Regulation on 03.08.2017, at 2.99% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

2.99%

Voting rights sold

Voting rights acquired0%

Voting rights sold2.99%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

RENAISSANCE TECHNOLOGIES LLC disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 03.08.2017.

Publication date03.08.2017

Transaction date27.07.2017

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerRENAISSANCE TECHNOLOGIES LLC

Declared addressRENAISSANCE TECHNOLOGIES LLC, 10022 New York, NY

CategoryCollective investment vehicle

Voting rights acquired0%

Voting rights sold2.99%

Below threshold0%

ExchangeXSWX

Notification IDTCH8200022

Source: SIX Exchange Regulation · Publication date: 03.08.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open